Hakutulokset - Gee‐Chen Chang

Tarkenna hakua
  1. 1
    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum

    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum Tekijä Wei‐Yu Liao, Jin‐Yuan Shih, Gee‐Chen Chang, Yu-Kai Cheng, James Chih‐Hsin Yang, Yuh‐Min Chen, Chong‐Jen Yu

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer Tekijä Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching‐Hsiung Lin, Min-Hsuan Chen, Gee‐Chen Chang, Meng-Feng Tsai, Jeremy J.W. Chen

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy Tekijä Jen‐Yi Lee, Yee-Ming Lee, Gee‐Chen Chang, Sung‐Liang Yu, Wan-Yu Hsieh, Jeremy J.W. Chen, Huei‐Wen Chen, Pan‐Chyr Yang

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)

    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS) Tekijä Parneet Cheema, Antonio Passaro, Charles E. Martin, Marcello Tiseo, K. Park, Gee‐Chen Chang, Yang Hu, Byoung Chul Cho, Margarida S. Miranda, A. Fernandes, H. Freitas

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer

    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer Tekijä Mei‐Chih Chen, Kun‐Chieh Chen, Gee‐Chen Chang, Ho Lin, Chun‐Chi Wu, Wei-Hsiang Kao, Chieh‐Lin Jerry Teng, Shih‐Lan Hsu, Tsung‐Ying Yang

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects

    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects Tekijä Yi‐Jing Hsiao, Min-Shu Hsieh, Gee‐Chen Chang, Yin-Chen Hsu, C Y Wang, Yan-Ming Chen, Yi-Ling Chen, Pan‐Chyr Yang, Sung‐Liang Yu

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients Tekijä Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen, Kang‐Yi Su, Sung‐Liang Yu, Jeremy J.W. Chen, Yen-Hsiang Huang, Gee‐Chen Chang

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo

    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo Tekijä Chieh‐Shan Wu, Yun‐Ju Chen, Jeremy J.W. Chen, Jeng‐Jer Shieh, Chia-Hsin Huang, Pei-Shan Lin, Gee‐Chen Chang, JingHua-Tsai Chang, Chi‐Chen Lin

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer Tekijä Ming‐Fang Wu, Chih-An Lin, Tzu‐Hang Yuan, Hsiang‐Yuan Yeh, Sheng‐Fang Su, Chin‐Lin Guo, Gee‐Chen Chang, Ker-Chau Li, Chao‐Chi Ho, Huei‐Wen Chen

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma

    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma Tekijä Pei-Fang Hung, Tse‐Ming Hong, Yi‐Chiung Hsu, Hsuan‐Yu Chen, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Yuh‐Shan Jou, Szu‐Hua Pan, Pan‐Chyr Yang

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma

    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma Tekijä Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma

    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma Tekijä Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Kun‐Chieh Chen, Kuo-Hsuan Hsu, Meen-Hsin Tsai, Sung‐Liang Yu, Kang‐Yi Su, Jeremy J.W. Chen, Gee‐Chen Chang

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target

    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target Tekijä Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze‐Sing Huang, Ching-Chuan Kuo, Pei‐Yi Chu, Yi‐Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee‐Chen Chang, Ko-Jiunn Liu

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program

    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program Tekijä Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC

    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC Tekijä Yi‐Long Wu, Byoung Chul Cho, Qing Zhou, Gee‐Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martín, Gilberto de Castro, Johan Vansteenkiste, David Vicente, A. Milner, James R. Rigas, Y. Chen, Mariano Provencio

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Ca... Tekijä Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Min‐Liang Kuo, James Chih‐Hsin Yang, Wing‐Kai Chan, Bing‐Ching Ho, Gee‐Chen Chang, Jin‐Yuan Shih, Sung‐Liang Yu, Pan‐Chyr Yang

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma

    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma Tekijä Chi-Chung Wang, Kang‐Yi Su, Hsuan‐Yu Chen, So-Yi Chang, Chi-Fan Shen, Chia-Hung Hsieh, Qi-Sheng Hong, Ching-Cheng Chiang, Gee‐Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarc... Tekijä Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Kun‐Chieh Chen, Chia-Hung Hsu, Kang‐Yi Su, Jeremy J.W. Chen, Huei‐Wen Chen, Sung‐Liang Yu, Tsung‐Ying Yang, Gee‐Chen Chang

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report Tekijä James Chih‐Hsin Yang, Frances A. Shepherd, Dong‐Wan Kim, Gyeong‐Won Lee, Jong Seok Lee, Gee‐Chen Chang, Sung Sook Lee, Yu‐Feng Wei, Yun Gyoo Lee, Gianluca Laus, Barbara Collins, Francesca Pisetzky, Leora Horn

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis

    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis Tekijä Pei-Fang Hung, Tse‐Ming Hong, Che‐Chang Chang, Chung‐Lieh Hung, Yuan-Ling Hsu, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Nei‐Li Chan, Sung‐Liang Yu, Pan‐Chyr Yang, Szu‐Hua Pan

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: